| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/24/1997 | EP0711111A4 Novel stem cell marker |
| 09/24/1997 | CN1160420A Pesticidal proteins and strains |
| 09/24/1997 | CN1160345A Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 09/23/1997 | US5670634 Inhibit expression of peptide of alzheimer's disease and down's syndrome |
| 09/23/1997 | US5670623 Methods of use of cellulose binding domain proteins |
| 09/23/1997 | US5670483 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 09/23/1997 | US5670372 Pluripotential embryonic stem cells and methods of making same |
| 09/23/1997 | US5670367 Recombinant fowlpox virus |
| 09/23/1997 | US5670361 HIV-specific ribozymes |
| 09/23/1997 | US5670360 Nucleic acid dna with sequences and screening for agonists |
| 09/23/1997 | US5670358 Method for inhibiting chymopapain and papain enzyme activity with polysaccharides of animal origin |
| 09/23/1997 | US5670357 Peroxidase produced by plant cell cultures |
| 09/23/1997 | US5670354 Use of VSV-G pseudotyped vectors for transfer of genes into embryos |
| 09/23/1997 | US5670351 Methods and compositions for the ex vivo replication of human hematopoietic stem cells |
| 09/23/1997 | US5670349 Hydroxymethylglutaryl coenzyme a reductase genetic engineering |
| 09/23/1997 | US5670347 Peptide-mediated gene transfer |
| 09/23/1997 | US5670342 Stimulate the proliferation and differentiation of colon epithelial cells |
| 09/23/1997 | US5670339 DNA encoding single chain monellin |
| 09/23/1997 | US5670319 Assay for tumor necrosis factor receptor-associated factors |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670147 Compositions containing cultured mitotic human stem cells |
| 09/23/1997 | US5670146 Pharmacological preparations comprising human pluripotent hematopoietic colony stimulating factor |
| 09/18/1997 | WO1997034146A1 Inhibiting protein interactions |
| 09/18/1997 | WO1997034143A1 Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway |
| 09/18/1997 | WO1997034007A1 Promoter |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033989A1 TRANSGENIC ANIMALS HAVING A DISRUPTED eNOS GENE AND USE THEREOF |
| 09/18/1997 | WO1997033979A1 Transgenic model of hepatitis c virus infection |
| 09/18/1997 | WO1997033978A1 Hematopoietic cell culture nutrient supplement |
| 09/18/1997 | WO1997033975A1 Medium for preserving biological materials |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033611A1 Method of killing target cells in harvested cell populations with one or more immunotoxins |
| 09/18/1997 | WO1997033473A1 Method for reducing bcl-2 expressing cells resistance to death |
| 09/18/1997 | WO1997033470A1 Method and media for enhancing viability, maturation, and cryopreservation of cells |
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | WO1997020569A3 Bioartificial devices and cellular matrices therefor |
| 09/18/1997 | DE19608813A1 Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen Conjugate for influencing protein-protein interactions |
| 09/18/1997 | CA2248998A1 Inhibiting protein interactions |
| 09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
| 09/18/1997 | CA2248707A1 Clostridium perfringens vaccines |
| 09/18/1997 | CA2248620A1 Method of killing target cells in harvested cell populations with one or more immunotoxins |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248541A1 Mouse tec tyrosine kinase promoter |
| 09/18/1997 | CA2248200A1 Medium for preserving biological materials |
| 09/18/1997 | CA2248142A1 Hematopoietic cell culture nutrient supplement |
| 09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/17/1997 | EP0795608A1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 09/17/1997 | EP0795606A1 Process for producing transformed cell |
| 09/17/1997 | EP0795021A2 Retroviral delivery of full length factor viii |
| 09/17/1997 | EP0795020A1 Plant stearoyl-acp thioesterase sequences and methods to increase stearate content in plant seed oils |
| 09/17/1997 | EP0795019A2 Genetic transformation using a parp inhibitor |
| 09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
| 09/17/1997 | EP0795014A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 09/17/1997 | EP0795008A1 Chondrocyte cell-lines |
| 09/17/1997 | EP0795007A1 Bioengineered human blood cells |
| 09/17/1997 | EP0795006A1 HUMAN MutT2 |
| 09/17/1997 | EP0794958A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794790A1 Localized delivery of factors enhancing survival of transplanted cells |
| 09/17/1997 | CN1159833A Transgenic plants producing trehalose |
| 09/17/1997 | CN1159831A Vaccines containing borrelia burgdorferi OSPG |
| 09/17/1997 | CN1159829A 17q-linked breast and ovarian cancer susceptibility gene |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/16/1997 | US5668256 Chimeric interleukin 5-receptor/immunoglobulin polypeptides |
| 09/16/1997 | US5667998 Efficient gene transfer into primary lymphocytes obviating the need for drug selection |
| 09/16/1997 | US5667997 Biosynthesis of medium chain fatty acids |
| 09/16/1997 | US5667966 Mouse monoclonal antibodies to Hepatitis E virus and methods for using same |
| 09/16/1997 | US5667961 Skin substitute |
| 09/16/1997 | US5667839 Human recombinant collagen in the milk of transgenic animals |
| 09/16/1997 | US5667780 Sensory and motor neuron derived factor and binding |
| 09/16/1997 | US5667778 Injectable bladder muscle cells-polymer suspension for treatment of vesicoureteral reflux and incontinence |
| 09/16/1997 | US5667777 Gene therapy for treatment of glomerular kidney disease, expression of beta-galactosidase |
| 09/12/1997 | WO1997032994A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | WO1997032992A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 09/12/1997 | WO1997032985A1 Nucleic acid molecules coding for debranching enzymes from maize |
| 09/12/1997 | WO1997032980A1 Transferrin receptor genes of moraxella |
| 09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
| 09/12/1997 | WO1997032977A1 Plastid transformation in arabidopsis thaliana |
| 09/12/1997 | WO1997032974A1 Alpha-galactosidase |
| 09/12/1997 | WO1997032972A1 Immortalized hepatocytes |
| 09/12/1997 | WO1997032970A1 Modified rapid expansion methods ('modified-rem') for in vitro propagation of t lymphocytes |
| 09/12/1997 | WO1997032900A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032891A2 Conjugate for modifying interactions between proteins |
| 09/12/1997 | WO1997032889A1 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 09/12/1997 | WO1997032608A1 Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system |
| 09/12/1997 | WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | WO1997023598A3 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |